| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.7 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.072 | 0.7 |